MozavaptanAlternative Names: OPC 31260; Physuline
Latest Information Update: 08 Sep 2011
At a glance
- Originator Otsuka Pharmaceutical
- Class Antihypertensives; Benzazepines; Cardiotonics
- Mechanism of Action Vasopressin V2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Hyponatraemia
- Discontinued Hypertension; Polycystic kidney disease; Postmyocardial infarction